Search research articles
Contact Us
Filters
Showing results (181-190 of 258) with videos related to
Page
of 26
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
February 15, 2003
Usefulness of breast MRI in a patient with genetic risk
L Cortesi, B Canossi, M De Santis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2013
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women
L Cortesi, E Razzaboni, A Toss, et al.
Pediatric Blood & Cancer
|
February 3, 2015
The role of chest computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma
Sara M Federico, Samuel L Brady, Alberto Pappo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 4, 2024
Autologous mitochondrial transplant for acute cerebral ischemia: Phase 1 trial results and review
Melanie Walker, Michael R Levitt, Emma M Federico, et al.
Haematologica
|
September 1, 1993
Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial
M Brugiatelli, M Federico, P G Gobbi, et al.
Haematologica
|
November 1, 1996
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL)
P G Gobbi, C Pieresca, L Cavanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi Experience
P G Gobbi, C Pieresca, A Frassoldati, et al.
Haematologica
|
February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry
C Stelitano, L Baldini, C Pieresca, et al.
Haematologica
|
September 5, 2001
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas
C Guglielmi, M Martelli, M Federico, et al.
Minerva Medica
|
November 3, 1979
[Clinico-immunological study of 6 cases of Behçet's disease]
V Silingardi, C Montemurno, L Venezia, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 258) with videos related to
Sort By:
Page
of 26
Journal of Experimental & Clinical Cancer Research : CR
|
February 15, 2003
Usefulness of breast MRI in a patient with genetic risk
L Cortesi, B Canossi, M De Santis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 27, 2013
A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women
L Cortesi, E Razzaboni, A Toss, et al.
Pediatric Blood & Cancer
|
February 3, 2015
The role of chest computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma
Sara M Federico, Samuel L Brady, Alberto Pappo, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
December 4, 2024
Autologous mitochondrial transplant for acute cerebral ischemia: Phase 1 trial results and review
Melanie Walker, Michael R Levitt, Emma M Federico, et al.
Haematologica
|
September 1, 1993
Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial
M Brugiatelli, M Federico, P G Gobbi, et al.
Haematologica
|
November 1, 1996
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL)
P G Gobbi, C Pieresca, L Cavanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
Vinblastine, bleomycin, and methotrexate chemotherapy plus extended-field radiotherapy in early, favorably presenting, clinically staged Hodgkin's patients: the Gruppo Italiano per lo Studio dei Linfomi Experience
P G Gobbi, C Pieresca, A Frassoldati, et al.
Haematologica
|
February 22, 2000
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry
C Stelitano, L Baldini, C Pieresca, et al.
Haematologica
|
September 5, 2001
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas
C Guglielmi, M Martelli, M Federico, et al.
Minerva Medica
|
November 3, 1979
[Clinico-immunological study of 6 cases of Behçet's disease]
V Silingardi, C Montemurno, L Venezia, et al.
Page
of 26